{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:03Z","timestamp":1787041683326,"version":"build-2736575974"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119090","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:21:08Z","timestamp":1782170468000},"page":"119090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of long non-coding RNAs in therapeutic resistance and clinical applications in cancer"],"prefix":"10.1016","volume":"317","author":[{"given":"Md Abdus","family":"Samad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasimudeen R.","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Rehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Kashif","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams","family":"Tabrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib1","article-title":"The financial toxicity of cancer: unveiling global burden and risk factors \u2013 a systematic review and meta-analysis","volume":"10","author":"Atamenta Kitaw","year":"2025","journal-title":"BMJ Glob. Heal."},{"key":"10.1016\/j.ejmech.2026.119090_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: an emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-024-01532-8","article-title":"Long non-coding RNAs (lncRNAs) in cancer development: new insight from STAT3 signaling pathway to immune evasion","volume":"25","author":"Ma","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2026.119090_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217297","article-title":"LncRNAs and the cancer epigenome: mechanisms and therapeutic potential","volume":"605","author":"Nadhan","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119090_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41417-024-00734-2","article-title":"Emerging role of RNA modification and long noncoding RNA interaction in cancer","volume":"31","author":"Yang","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-023-02741-x","article-title":"Involvement of lncRNAs in cancer cells migration, invasion and metastasis: Cytoskeleton and ECM crosstalk","volume":"42","author":"Ahmad","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119090_bib7","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3390\/ijms26104535","article-title":"Therapeutic applications of Poly-miRNAs and miRNA sponges","volume":"26","author":"Avenda\u00f1o-Portugal","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119090_bib8","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s11010-024-04933-1","article-title":"Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy","volume":"479","author":"Kadian","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/cancers17030382","article-title":"Deciphering the role of cancer stem cells: drivers of tumor evolution, therapeutic resistance, and precision medicine strategies","volume":"17","author":"El-Tanani","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119090_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189440","article-title":"Cancer stem cells in focus: deciphering the dynamic functional landscape of stemness in cancer","volume":"1880","author":"Nwokolo","year":"2025","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188899","article-title":"Long non-coding RNAs: fundamental regulators and emerging targets of cancer stem cells","volume":"1878","author":"Shabna","year":"2023","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12935-022-02653-4","article-title":"Functional interplay between long non-coding RNAs and breast CSCs","volume":"22","author":"Hussen","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.119090_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112306","article-title":"Association between lncRNAs with stem cells in cancer; a particular focus on lncRNA-CSCs axis in cancer immunopathogenesis","volume":"136","author":"Obaid Saleh","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119090_bib15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.7150\/ijbs.80873","article-title":"LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression","volume":"19","author":"Jiang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"39","key":"10.1016\/j.ejmech.2026.119090_bib16","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.2174\/0929867329666220510090418","article-title":"Long non-coding RNA SNHG16 facilitates esophageal cancer cell proliferation and self-renewal through the microRNA-802\/PTCH1 axis","volume":"29","author":"Zhang","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119090_bib17","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.7150\/jca.95852","article-title":"Linc00662 sponges miR-15b-5p to promote hypopharyngeal squamous cell carcinoma progression by facilitating cancer stem cell-like phenotypes","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119090_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.reth.2022.11.005","article-title":"Cancer stem cell-like cells-derived exosomal lncRNA CDKN2B-AS1 promotes biological characteristics in thyroid cancer via miR-122-5p\/P4HA1 axis","volume":"22","author":"Wu","year":"2023","journal-title":"Regen. Ther."},{"key":"10.1016\/j.ejmech.2026.119090_bib19","first-page":"1","article-title":"LncRNA DBH-antisense RNA 1 modulates the miR-612\/SOX4 axis as a CeRNA to regulate the properties of liver cancer stem cells and their resistance to lenvatinib","author":"Wu","year":"2025","journal-title":"Adv. Tradit. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119090_bib20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/tox.23468","article-title":"Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability","volume":"37","author":"Mao","year":"2022","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-023-01442-w","article-title":"N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness","volume":"9","author":"Dong","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-03181-5","article-title":"LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p\/SPP1 axis as a ceRNA","volume":"24","author":"Ouyang","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/biof.1813","article-title":"LncRNA LOC100507144 acts as a novel regulator of CD44\/Nanog\/Sox2\/miR-302\/miR-21 axis in colorectal cancer","volume":"48","author":"Ebrahimi","year":"2022","journal-title":"BioFactors"},{"issue":"50","key":"10.1016\/j.ejmech.2026.119090_bib25","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1038\/s41388-022-02538-w","article-title":"LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination","volume":"41","author":"Tsang","year":"2022","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119090_bib26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1080\/15384101.2022.2040282","article-title":"LINC01234 regulates microRNA-27b-5p to induce the migration, invasion and self-renewal of ovarian cancer stem cells through targeting SIRT5","volume":"21","author":"Ke","year":"2022","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12935-024-03549-1","article-title":"Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer","volume":"24","author":"Ge","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119090_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27207","article-title":"Long non-coding RNAs in drug resistance across the top five cancers: update on their roles and mechanisms","volume":"10","author":"Shi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.119090_bib30","article-title":"Therapeutic resistance in cancer: lncRNAs as modulators and targets for cancer therapy","author":"Ali","year":"2025","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ymthe.2021.06.006","article-title":"lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-023-02874-z","article-title":"m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma","volume":"43","author":"Lin","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113335","article-title":"LncRNA AC026401.3 interacts with OCT1 to intensify sorafenib and lenvatinib resistance by activating E2F2 signaling in hepatocellular carcinoma","volume":"420","author":"Wang","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-09033-7","article-title":"LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.ejmech.2026.119090_bib35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41388-024-02972-y","article-title":"LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance","volume":"43","author":"Yang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.119090_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101351","article-title":"Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p\/EIF5A2 pathway","volume":"18","author":"Jiang","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejmech.2026.119090_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216828","article-title":"LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3","volume":"589","author":"Zhu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-024-01866-y","article-title":"LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119090_bib39","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41388-022-02253-6","article-title":"Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119090_bib40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/1541-7786.MCR-22-0458","article-title":"Exosomal lincROR promotes docetaxel resistance in prostate cancer through a b-catenin\/HIF1a positive feedback loop","volume":"21","author":"Jiang","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-06084-5","article-title":"The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer","volume":"14","author":"Ren","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s11033-026-11886-9","article-title":"Long non-coding RNAs as modulators of endocrine therapy response in hormone receptor-positive breast cancer","volume":"53","author":"Shukla","year":"2026","journal-title":"Mol. Biol. Reports"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.20517\/jtgg.2025.67","article-title":"The role of long non-coding RNAs in breast cancer drug resistance: a comprehensive review","volume":"9","author":"Xu","year":"2025","journal-title":"J Transl Genet Genom"},{"issue":"19","key":"10.1016\/j.ejmech.2026.119090_bib44","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-23-0015","article-title":"LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity","volume":"83","author":"Yu","year":"2023","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119090_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206663","article-title":"Estrogen-induced LncRNA, LINC02568, promotes estrogen receptor-positive breast cancer development and drug resistance through both in trans and in Cis mechanisms","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"issue":"40","key":"10.1016\/j.ejmech.2026.119090_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3821","article-title":"LncRNA EILA promotes CDK4\/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein","volume":"9","author":"Cai","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119090_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01292","article-title":"The role of long non-coding RNAs in immunotherapy resistance","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","article-title":"Targeting and engineering long non-coding RNAs for cancer therapy","volume":"25","author":"Coan","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejmech.2026.119090_bib49","article-title":"Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119090_bib50","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3390\/cells11172688","article-title":"The CDK1-Related lncRNA and CXCL8 mediated immune resistance in lung adenocarcinoma","volume":"11","author":"Xue","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119090_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004666","article-title":"Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119090_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114485","article-title":"Non-coding RNAs in radiotherapy resistance: roles and therapeutic implications in gastrointestinal cancer","volume":"161","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21785-1","article-title":"LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis","volume":"12","author":"Xie","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119090_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101034","article-title":"LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44","volume":"56","author":"Mi","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2026.119090_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.791889","article-title":"LncRNA LINC01134 contributes to radioresistance in hepatocellular carcinoma by regulating DNA damage response via MAPK signaling pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10142-024-01330-1","article-title":"Long non-coding RNA CCAT1 acts as an oncogene to promote radiation resistance in lung adenocarcinoma: an epigenomics-based investigation","volume":"24","author":"Li","year":"2024","journal-title":"Funct. Integr. Genomics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41418-022-01049-1","article-title":"A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3","volume":"30","author":"Zhou","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119090_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101304","article-title":"LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1","volume":"18","author":"Xiao","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejmech.2026.119090_bib60","article-title":"Long non-coding RNAs in ferroptosis, pyroptosis and necroptosis: from functions to clinical implications in cancer therapy","volume":"14","author":"Huang","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib61","article-title":"Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Reports"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00432-024-05682-w","article-title":"Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas","volume":"150","author":"Long","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71445","article-title":"A novel MPT\u2010Driven necrosis\u2010related lncRNA signature for prognostic prediction in hepatocellular carcinoma: validation using organoids","volume":"15","author":"Liu","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12010-024-05014-1","article-title":"Deciphering the role of necroptosis-related long non-coding RNAs in hepatocellular carcinoma: a necroptosis-related lncRNA-Based signature to predict the prognosis of hepatocellular carcinoma","volume":"197","author":"Ye","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119090_bib65","article-title":"A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE\/miR-23b-3p\/IDH1 regulatory axis in glioma","volume":"15","author":"Chen","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-022-02421-8","article-title":"Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119090_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37403","article-title":"Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.119090_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1001347","article-title":"A novel necroptosis-related lncRNA signature predicts the prognosis of lung adenocarcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib69","first-page":"1","article-title":"Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Reports"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-025-15229-y","article-title":"Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119090_bib71","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1007\/s00432-023-04886-w","article-title":"Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer","volume":"149","author":"Sun","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119090_bib72","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.3390\/cancers14184364","article-title":"Identification and validation of the lncRNA MYOSLID as a regulating factor of necroptosis and immune cell infiltration in colorectal cancer following necroptosis-related LncRNA model establishment","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.119090_bib73","article-title":"Prediction of prognosis and immunotherapy of Osteosarcoma based on necroptosis-related lncRNAs","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.119090_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.948254","article-title":"A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.119090_bib75","article-title":"Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer","volume":"12","author":"He","year":"2022","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119090_bib76","doi-asserted-by":"crossref","first-page":"12947","DOI":"10.1007\/s00432-023-05158-3","article-title":"A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients","volume":"149","author":"Kong","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib77","first-page":"221","article-title":"Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity","volume":"15","author":"Gao","year":"2025","journal-title":"Sci. Reports"},{"key":"10.1016\/j.ejmech.2026.119090_bib78","article-title":"Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12957-022-02727-7","article-title":"Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma","volume":"20","author":"Wang","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119090_bib80","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.21037\/tcr-24-450","article-title":"The LINC00957\/miR-17-5p axis regulates the cell cycle and migration in glioblastoma via the cuproptosis-related gene nephronectin","volume":"13","author":"Duan","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib81","first-page":"1","article-title":"Novel cuproptosis-related lncRNAs risk model to predicting prognosis and guiding immunotherapy for OSCC patients","volume":"16","author":"Kong","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119090_bib82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10495-022-01790-5","article-title":"Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma","volume":"28","author":"Sun","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-024-03219-6","article-title":"Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs","volume":"24","author":"Wei","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119090_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18519","article-title":"Deciphering the role of cuproptosis-related lncRNAs in shaping the lung cancer immune microenvironment: a comprehensive prognostic model","volume":"28","author":"Huang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119090_bib85","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.7150\/jca.82370","article-title":"A five-cuproptosis-related LncRNA signature: predicting prognosis, assessing immune function & drug sensitivity in lung squamous cell carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119090_bib86","article-title":"Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119090_bib87","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1007\/s00432-023-04916-7","article-title":"A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer","volume":"149","author":"Wang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-023-01487-x","article-title":"Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer","volume":"16","author":"Pang","year":"2023","journal-title":"BMC Med. Genomics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib89","first-page":"1","article-title":"Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Discov. Oncol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib90","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.21037\/tcr-23-61","article-title":"Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma","volume":"12","author":"Hu","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119090_bib91","article-title":"Identification of telomere-related lncRNAs and immunological analysis in ovarian cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00432-022-04456-6","article-title":"A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer","volume":"149","author":"Feng","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib93","article-title":"Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Reports"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12957-024-03514-2","article-title":"As a novel prognostic model for breast cancer, the identification and validation of telomere-related long noncoding RNA signatures","volume":"22","author":"Zhao","year":"2024","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00432-022-04456-6","article-title":"A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer","volume":"149","author":"Feng","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119090_bib96","series-title":"A Prognostic Model of Clear Cell Renal Cell Carcinoma Based on telomere-related Lncrnas","author":"Chen","year":"2023"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-56913-8","article-title":"Antisense oligonucleotide-mediated TRA2\u03b2 poison exon inclusion induces the expression of a lncRNA with anti-tumor effects","volume":"16","author":"Leclair","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-025-04978-2","article-title":"Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1","volume":"173","author":"Saini","year":"2025","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119090_bib99","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s12276-022-00791-3","article-title":"LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription","volume":"54","author":"Luo","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-23802-9","article-title":"Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin","volume":"12","author":"Berhane","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119090_bib101","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/cancers16101876","article-title":"Dysregulation of lncRNA MALAT1 contributes to lung cancer in African Americans by modulating the tumor immune microenvironment","volume":"16","author":"Li","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119090_bib102","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/2326-6066.CIR-23-0045","article-title":"Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple-negative breast cancer","volume":"11","author":"Adewunmi","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-024-01955-7","article-title":"The therapeutically actionable long non-coding RNA \u2018T-RECS\u2019 is essential to cancer cells' survival in NRAS\/MAPK-driven melanoma","volume":"23","author":"Feichtenschlager","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119090_bib104","first-page":"1","article-title":"aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative splicing","author":"Lei","year":"2025","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-025-00742-6","article-title":"IL-6-induced long noncoding RNA MIR3142HG promotes tumorigenesis by interacting with thioredoxin-1 and STAT3 in human colorectal cancer","volume":"30","author":"Fang","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2026.119090_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109980","article-title":"Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2","volume":"755","author":"Zou","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.119090_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110306","article-title":"LncRNA HOTAIR sponges miR-301a-3p to promote glioblastoma proliferation and invasion through upregulating FOSL1","volume":"94","author":"Guo","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119090_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101983","article-title":"Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer","volume":"46","author":"Duan","year":"2024","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib109","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10266-024-00899-0","article-title":"lncRNA TMEM161B-AS1 screened the onset of oral squamous cell carcinoma in HPV-infected patients, predicted poor prognosis, and regulated cell progression via modulating the miR-651-5p\/BDNF axis","volume":"112","author":"Wang","year":"2024","journal-title":"Odontology"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/ncrna8040061","article-title":"Knockdown of lncRNA TP53TG1 enhances the efficacy of sorafenib in human hepatocellular carcinoma cells","volume":"8","author":"Lu","year":"2022","journal-title":"Non-Coding RNA"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15384101.2022.2111929","article-title":"LncRNA-UCA1 regulates lung adenocarcinoma progression through competitive binding to miR-383","volume":"22","author":"Tang","year":"2023","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acs.bioconjchem.4c00001","article-title":"Assessment of the efficacy of the combination of RNAi of lncRNA DANCR with chemotherapy to treat triple negative breast cancer using magnetic resonance molecular imaging","volume":"35","author":"Nicolescu","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119090_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148900","article-title":"lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel","volume":"932","author":"Naseri","year":"2025","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib114","first-page":"1","article-title":"Long non-coding RNA NEAT1 promotes colorectal cancer progression via interacting with SIRT1","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib115","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1080\/21655979.2021.2023984","article-title":"Knockdown of lncRNA HAGLROS inhibits metastasis and promotes apoptosis in nephroblastoma cells by inhibition of autophagy","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib116","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","article-title":"The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription","volume":"3","author":"Xia","year":"2022","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21037\/jtd-22-1826","article-title":"LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity","volume":"15","author":"She","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-025-03461-0","article-title":"The LncRNA STEAP3-AS1 promotes liver metastasis in colorectal cancer by regulating histone lactylation through chromatin remodelling","volume":"44","author":"Lv","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119090_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70956","article-title":"Knockdown of p53 enhances LncRNA A2M-AS1 inhibition of pancreatic cancer progression via regulating MAPK pathway","volume":"14","author":"Cen","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-025-14600-3","article-title":"LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells","volume":"25","author":"Han","year":"2025","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-025-02845-8","article-title":"Exosomal long non-coding RNAs in human malignancies: biological functions and clinical applications","volume":"42","author":"Almouh","year":"2025","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-025-00801-y","article-title":"Exosomes carrying lncRNA FLG-AS1 overexpression vectors inhibit the tumorigenesis of oral squamous cell carcinoma via fat mass and obesity-associated protein-mediated m6A modification","volume":"77","author":"Xia","year":"2025","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-04640-z","article-title":"M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5\/NF-\u03baB pathway","volume":"13","author":"Jiang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119090_bib124","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s12033-023-00795-y","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomal lncRNA FAM99B represses hepatocellular carcinoma cell malignancy","volume":"66","author":"Xu","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119090_bib125","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.62347\/YRJK5888","article-title":"Engineered exosomes transporting the lncRNA, SVIL-AS1, inhibit the progression of lung cancer via targeting miR-21-5p","volume":"14","author":"Xu","year":"2024","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.ejmech.2026.119090_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126147","article-title":"CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy","volume":"250","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119090_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215781","article-title":"Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis","volume":"543","author":"Liu","year":"2022","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2102360","article-title":"BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression","volume":"23","author":"Liu","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2026.119090_bib129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.01.026","article-title":"Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy","volume":"343","author":"Huang","year":"2022","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119090_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7308","article-title":"Exosome-related lncRNA score: a value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma","volume":"13","author":"Yang","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13008-024-00110-4","article-title":"Exosome-derived lncRNA A1BG-AS1 attenuates the progression of prostate cancer depending on ZC3H13-mediated m6A modification","volume":"19","author":"Yang","year":"2024","journal-title":"Cell Div"},{"key":"10.1016\/j.ejmech.2026.119090_bib132","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.actbio.2023.06.011","article-title":"LncRNA SELL\/L-selectin promotes HPV-positive HNSCC progression and drives fucoidan-mediated therapeutic strategies","volume":"167","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib133","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10528-023-10541-3","article-title":"Exosomal lncRNA LINC02191 promotes laryngeal squamous cell carcinoma progression by targeting miR-204-5p\/RAB22A axis and regulating PI3K\/Akt\/mTOR pathway","volume":"62","author":"Kang","year":"2024","journal-title":"Biochem. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib134","first-page":"1","article-title":"Precision nanomedicine: Lapatinib-loaded Chitosan-Gold nanoparticles targeting LINC01615 for lung cancer therapy","volume":"27","author":"Rezaei Aghdam","year":"2025","journal-title":"AAPS J"},{"issue":"26","key":"10.1016\/j.ejmech.2026.119090_bib135","doi-asserted-by":"crossref","first-page":"22743","DOI":"10.1021\/acsomega.2c02260","article-title":"Regulating oncogenic LncRNA DANCR with targeted ECO\/siRNA nanoparticles for non-small cell lung cancer therapy","volume":"7","author":"Nicolescu","year":"2022","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib136","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.apsb.2022.12.004","article-title":"Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis","volume":"13","author":"Yang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-023-02168-8","article-title":"Coordinated modulation of long non-coding RNA ASBEL and curcumin co-delivery through multicomponent nanocomplexes for synchronous triple-negative breast cancer theranostics","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ejmech.2026.119090_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215916","article-title":"Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer","volume":"549","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119090_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105077","article-title":"Chitosan-Gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer","volume":"9","author":"Zhou","year":"2022","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/09205063.2024.2410060","article-title":"In vivo delivery of PBAE\/ZIF-8 enhances the sensitivity of colorectal cancer to doxorubicin through sh-LncRNA ASB16-AS1","volume":"36","author":"Yang","year":"2025","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02467-2","article-title":"Transfection with Plasmid-encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma","volume":"41","author":"Mao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119090_bib142","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1166\/mex.2022.2273","article-title":"Mechanism research on long noncoding RNA (lncRNA) GASL1 carried with lipid nanoparticles in restraining cervical carcinoma transplantable tumor through targeting of miR-21 and induction of STAT3\/survivin signal channel","volume":"12","author":"Liu","year":"2023","journal-title":"Mater. Express"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119090_bib143","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s13365-022-01089-w","article-title":"The evaluation expression of non-coding RNAs in response to HSV-G47\u0394 oncolytic virus infection in glioblastoma multiforme cancer stem cells","volume":"28","author":"Vazifehmand","year":"2022","journal-title":"J. NeuroVirology"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119090_bib144","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jmv.27578","article-title":"LncRNA LINC00924 upregulates NDRG2 to inhibit epithelial-mesenchymal transition via sponging miR-6755-5p in hepatitis B virus-related hepatocellular carcinoma","volume":"94","author":"Yu","year":"2022","journal-title":"J. Med. Virol."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119090_bib145","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8115","article-title":"Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.119090_bib146","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2020.03.012","article-title":"Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer","volume":"479","author":"Ang","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib147","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/JVI.01280-19","article-title":"HIV-1 tat interacts with a Kaposi's Sarcomaassociated herpesvirus reactivation-upregulated antiangiogenic long noncoding RNA, LINC00313, and antagonizes its function","volume":"94","author":"Yang","year":"2020","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119090_bib148","first-page":"10443","article-title":"LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer","volume":"23","author":"Zheng","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0436-6","article-title":"Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer","volume":"35","author":"Wang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119090_bib150","doi-asserted-by":"crossref","first-page":"e2353","DOI":"10.1038\/cddis.2016.253","article-title":"Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103","volume":"7","author":"He","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119090_bib151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.omto.2019.03.003","article-title":"lncRNA UCA1-Mediated Cdc42 signaling promotes oncolytic vaccinia virus cell-to-cell spread in ovarian cancer","volume":"13","author":"Horita","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119090_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05256-z","article-title":"LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1\/2","volume":"13","author":"Hsu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-024-02016-0","article-title":"Sponging of five tumour suppressor miRNAs by lncRNA-KCNQ1OT1 activates BMPR1A\/BMPR1B-ACVR2A\/ACVR2B signalling and promotes chemoresistance in hepatocellular carcinoma","volume":"10","author":"Majumdar","year":"2024","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100964","article-title":"106P Knockout of lncRNA-CCAT1 with the use of CRISPR-Cas9 system and G7 PAMAM dendrimers influences apoptosis and proliferations of NSCLC cells","volume":"8","author":"Iwanski","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12575-022-00171-1","article-title":"CRISPR\/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes","volume":"24","author":"Azadbakht","year":"2022","journal-title":"Biol. Proced. Online"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119090_bib156","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s12029-021-00669-z","article-title":"Evaluation of CRISPR\/Cas9 system effects on knocking Out NEAT1 gene in AGS gastric cancer cell line with therapeutic perspective","volume":"53","author":"Haghighi","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib157","first-page":"1","article-title":"Targeting the MALAT1 gene with the CRISPR\/Cas9 technique in prostate cancer","volume":"44","author":"Ahmadi-Balootaki","year":"2022","journal-title":"Gene Environ."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119090_bib158","article-title":"Evaluation of apoptosis, cell proliferation and cell cycle progression by inactivation of the NEAT1 long noncoding RNA in a renal carcinoma cell line using CRISPR\/Cas9","volume":"21","author":"Haghighi","year":"2023","journal-title":"Iran. J. Biotechnol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119090_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10142-024-01324-z","article-title":"CRISPR du-HITI an attractive approach to targeting Long noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell","volume":"24","author":"Moradi","year":"2024","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.ejmech.2026.119090_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117085","article-title":"Rapid detection of plasma exosomal LncRNA CASC9 for HCC using RT-RPA-CRISPR\/Cas12a assay","volume":"266","author":"Wu","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2026.119090_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119855","article-title":"The clinical value of rapidly detecting urinary exosomal lncRNA RMRP in bladder cancer with an RT-RAA-CRISPR\/Cas12a method","volume":"562","author":"Gao","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmech.2026.119090_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.627774","article-title":"CRISPR-Cas13-Mediated knockdown of lncRNA-GACAT3 inhibited cell proliferation and motility, and induced apoptosis by increasing p21, bax, and E-Cadherin expression in bladder cancer","volume":"7","author":"Zhang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119090_bib163","article-title":"CRISPR-CasRx targeting LncRNA LINC00341 inhibits tumor cell growth in vitro and in vivo","volume":"8","author":"Li","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119090_bib164","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.7150\/ijbs.33772","article-title":"A synthetic light-switchable system based on CRISPR Cas13a regulates the expression of LncRNA MALAT1 and affects the malignant phenotype of bladder cancer cells","volume":"15","author":"Qi","year":"2019","journal-title":"Int. J. Biol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:05:43Z","timestamp":1787040343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":164,"alternative-id":["S0223523426005350"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119090","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of long non-coding RNAs in therapeutic resistance and clinical applications in cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119090"}}